Koss Olinger Consulting LLC Sells 6,165 Shares of CVS Health Co. (NYSE:CVS)

Koss Olinger Consulting LLC cut its position in CVS Health Co. (NYSE:CVS) by 17.7% in the 4th quarter, Holdings Channel.com reports. The firm owned 28,719 shares of the pharmacy operator’s stock after selling 6,165 shares during the period. Koss Olinger Consulting LLC’s holdings in CVS Health were worth $1,289,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of CVS. MidAtlantic Capital Management Inc. bought a new position in CVS Health in the third quarter valued at about $25,000. Ridgewood Investments LLC raised its position in shares of CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 450 shares during the last quarter. Stonebridge Financial Group LLC bought a new position in shares of CVS Health during the fourth quarter worth about $28,000. Hopwood Financial Services Inc. bought a new position in shares of CVS Health during the fourth quarter worth about $29,000. Finally, Legacy Investment Solutions LLC bought a new position in shares of CVS Health during the third quarter worth about $31,000. 80.66% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on CVS shares. Piper Sandler lowered their price objective on CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a research report on Monday, November 25th. Argus set a $77.00 price objective on CVS Health in a research report on Tuesday, February 18th. Edward Jones raised CVS Health from a “hold” rating to a “buy” rating in a research note on Thursday, January 30th. Leerink Partnrs raised CVS Health from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, February 12th. Finally, Barclays raised their target price on CVS Health from $71.00 to $73.00 and gave the stock an “overweight” rating in a research note on Thursday, February 13th. Four equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, CVS Health presently has an average rating of “Moderate Buy” and a consensus price target of $69.83.

Insider Buying and Selling

In related news, SVP James David Clark sold 7,513 shares of CVS Health stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total transaction of $498,487.55. Following the sale, the senior vice president now directly owns 8,394 shares in the company, valued at approximately $556,941.90. This trade represents a 47.23 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Michael F. Mahoney purchased 30,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 18th. The shares were acquired at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the acquisition, the director now directly owns 39,356 shares of the company’s stock, valued at $2,625,045.20. This trade represents a 320.65 % increase in their position. The disclosure for this purchase can be found here. 0.24% of the stock is currently owned by corporate insiders.

CVS Health Stock Up 1.3 %

CVS stock opened at $67.49 on Wednesday. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $80.75. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80. The stock’s 50 day moving average is $59.32 and its 200-day moving average is $57.12. The firm has a market capitalization of $85.09 billion, a PE ratio of 18.44, a P/E/G ratio of 0.98 and a beta of 0.54.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, beating analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. Sell-side analysts expect that CVS Health Co. will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were issued a dividend of $0.665 per share. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 3.94%. CVS Health’s dividend payout ratio (DPR) is currently 72.68%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.